LALTOP significantly promoted the proliferation and migration of A549 and H1793 NSCLC cells, while antisense oligonucleotides which target LALTOP inhibited the malignant phenotypes of NSCLC. The gene discussed is LALTOP; the disease is non-small cell lung carcinoma.